Q72: Women’s health: PLAB/UK(MLA)/AKT Exam style question
A 25-year-old woman comes to your clinic seeking advice on the potential long-term effects of the combined oral contraceptive pill (COCP) on her health. Which of the following types of cancer has a reduced incidence in women taking the COCP?
A. Breast cancer
B. Cervical cancer
C. Ovarian cancer
D. Lung cancer
E. Pancreatic cancer
Explanations
The correct answer is C.
The combined oral contraceptive pill (COCP) is a widely used method of contraception containing both estrogen and progestogen. While it is an effective and convenient method, it also has various health effects that can influence a woman's risk of developing certain types of cancer.
In the context of this PLAB 1 / UKMLA question, the COCP has been shown to have a protective effect against ovarian cancer (Option C). This effect is thought to be due to the suppression of ovulation, which reduces the number of times the ovarian epithelium is disrupted and repaired. The protective effect increases with the duration of use and persists for many years after discontinuation of the COCP.
It is essential to note that the COCP has other effects on cancer risk:
Increased risk of breast and cervical cancer: Women who take the COCP have a slightly increased risk of developing breast cancer and cervical cancer compared to those who do not. The risk of breast cancer decreases over time after stopping the pill, while the risk of cervical cancer is related to the duration of use.
Protective against endometrial cancer: Similar to its protective effect on ovarian cancer, the COCP also reduces the risk of endometrial cancer. This is likely due to the progestogen component, which opposes the proliferative effects of estrogen on the endometrium.
In summary, the COCP has a complex impact on a woman's risk of developing certain types of cancer. It is essential to counsel patients on these potential risks and benefits and help them make an informed decision about their contraceptive options.
Other contraceptive options are heavily discussed in our platform, sign up to our PLAB or UKMLA services and get access to all the necessary materials required to pass the exam.
The above question is a high-yield exam PLAB 1 / UKMLA question-style question. At MedRevisions, We provide questions and not only explain the correct answer, we also explain the wrong answer so you will have a comprehensive understanding of the concepts that is commonly tested in the exam. On top of that, we also provide you PLAB 1 / UKMLA exam curated notes with no additional cost.
Join 100,000+ Members Study Group For UKMLA and PLAB 1 for FREE
At MedRevisions, we strive to provide the most up-to-date content available for the PLAB and UKMLA exams. We constantly add exam-style questions reflecting the high-yield concepts seen in recent exam trends and update our content to align with the latest NICE/CKS guidelines to help doctors prepare to pass the PLAB or UKMLA with confidence.
To discuss to more PLAB or UK-MLA exam style questions, Join: PLAB 1 /UKMLA exam study group
Past PLAB 1 candidates reviews about MedRevisions
Previous PLAB 1 or UKMLA exam guideline update
All MedRevisions recent updates
Are you a UK Medical Student taking your finals? Read our specific guide on How to Pass the MSCAA Exam.
What we provide and why MedRevisions is the best question bank and Study material available for the PLAB or UKMLA exam:
5000+ Questions: Covering every inch of the MLA Content Map.
Integrated Notes: Tailored Study Notes: Our comprehensive notes cover all key PLAB 1/UKMLA topics with clear explanations and highlighted take-home points. They’re designed to complement the question bank and reinforce your knowledge, making your revision as efficient as possible. Every important guideline, investigation, and management point you need to know is distilled for quick understanding.
Smart Analytics: We visualize your progress, showing you exactly which AoCPs (Areas of Clinical Practice) are your strongest and weakest.
MedRevisions AI Professor for PLAB and UKMLA: Imagine having a medical professor sitting next to you 24/7. A professor who knows exactly what you are studying, understands your weak spots, never gets tired of your questions, and has instant access to over 5,000+ exam-style questions and verified study notes. Read more about how to use MedRevisions AI Professor
Realistic Exam Simulation: Our question bank closely mirrors recent PLAB/UKMLA exams in style and difficulty. You’ll go into the exam feeling as if you’ve seen it all before, familiar with the question formats and level of complexity in each topic area.
Always Updated: Content is continuously aligned with the latest MLA content map and UK medical guidelines – we update promptly after each exam and after any guideline change. This means you’re always revising with relevant, up-to-date material, and never studying outdated advice or superseded protocols.
Proven Success: We have a strong track record of helping candidates excel in the PLAB and UKMLA exams on their first attempt. Our users’ successes are a testament to the effectiveness of our approach – and your success is our success.
30+ Full Mock Exams: Hone your exam technique with our library of full-length mock exams. We offer over 30 realistic mocks that simulate the actual PLAB 1, so you can practice under exam conditions. Even better, you can reset and retake these mocks as many times as you want – each attempt will bring a new mix of questions, giving you virtually endless practice and helping build your stamina for the real exam.
Study Essential Mode: Use our specialised high-yield Study Essential Mode to focus on the ~1,800 most essential questions first (as discussed above), then tackle the remaining questions for complete coverage. This feature helps you prioritize efficiently, solidifying core topics before moving on to more advanced or niche areas – a perfect antidote to feeling overwhelmed.
Reference:
Contraceptive services for under 25s | Guidance | NICE3: This is a public health guideline from NICE that provides recommendations on how to ensure that all young people have access to high-quality contraceptive services. It covers service design and delivery, information and advice, provision of methods, and training and education. It was published in March 2014.
Long-acting reversible contraception | Guidance | NICE4: This is a clinical guideline from NICE that covers long-acting reversible contraception (LARC) methods, such as intrauterine devices (IUDs), intrauterine systems (IUSs), contraceptive implants, and injectable contraceptives. It aims to increase the use of LARC by improving the information given to women about their contraceptive choices. It was published in October 2005.
